BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sobczak M, Sałaga M, Storr MA, Fichna J. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. J Gastroenterol 2014;49:24-45. [PMID: 23397116 DOI: 10.1007/s00535-013-0753-x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Spencer GW, Ong L, Gras SL. Beta casein proteins – A comparison between caprine and bovine milk. Trends in Food Science & Technology 2022. [DOI: 10.1016/j.tifs.2022.01.023] [Reference Citation Analysis]
2 Bach-Rojecky L, Vađunec D, Žunić K, Kurija J, Šipicki S, Gregg R, Mikula I, Primorac D. Continuing war on pain: a personalized approach to the therapy with nonsteroidal anti-inflammatory drugs and opioids. Per Med 2019;16:171-84. [PMID: 30484741 DOI: 10.2217/pme-2018-0116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Ma M, Wang Z, Wang J, Wei S, Cui J, Wang Y, Luo K, Zhao L, Liu X, Wang R. Endomorphin analog exhibited superiority in alleviating neuropathic hyperalgesia via weak activation of NMDA receptors. J Neurochem 2020;155:662-78. [DOI: 10.1111/jnc.15127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zhang L, Roy S. Opioid Modulation of the Gut-Brain Axis in Opioid-Associated Comorbidities. Cold Spring Harb Perspect Med 2021;11:a040485. [PMID: 32816876 DOI: 10.1101/cshperspect.a040485] [Reference Citation Analysis]
5 Juneja R. Opioids and cancer recurrence. Curr Opin Support Palliat Care. 2014;8:91-101. [PMID: 24759319 DOI: 10.1097/spc.0000000000000056] [Cited by in Crossref: 46] [Cited by in F6Publishing: 18] [Article Influence: 6.6] [Reference Citation Analysis]
6 Wright MH, Fetzer C, Sieber SA. Chemical Probes Unravel an Antimicrobial Defense Response Triggered by Binding of the Human Opioid Dynorphin to a Bacterial Sensor Kinase. J Am Chem Soc 2017;139:6152-9. [PMID: 28350441 DOI: 10.1021/jacs.7b01072] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
7 Wasilewski A, Lesniak A, Bujalska-zadrozny M, Sadowski B, Fichna J, Sacharczuk M. The effect of opioid agonists and antagonists on gastrointestinal motility in mice selected for high and low swim stress-induced analgesia. Neurogastroenterol Motil 2016;28:175-85. [DOI: 10.1111/nmo.12704] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Salaga M, Polepally PR, Zielinska M, Marynowski M, Fabisiak A, Murawska N, Sobczak K, Sacharczuk M, Do Rego JC, Roth BL, Zjawiony JK, Fichna J. Salvinorin A analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice. Br J Pharmacol 2015;172:4331-41. [PMID: 26040667 DOI: 10.1111/bph.13212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
9 Ostadhadi S, Azimi E, Lerner EA, Dehpour AR. Are itch and scratching the nausea and vomiting of skin? Exp Dermatol 2016;25:340-3. [PMID: 26739556 DOI: 10.1111/exd.12935] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
10 Howard AG 4th, Baker PA, Ibarra-García-Padilla R, Moore JA, Rivas LJ, Tallman JJ, Singleton EW, Westheimer JL, Corteguera JA, Uribe RA. An atlas of neural crest lineages along the posterior developing zebrafish at single-cell resolution. Elife 2021;10:e60005. [PMID: 33591267 DOI: 10.7554/eLife.60005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
11 Sałaga M, Polepally PR, Sobczak M, Grzywacz D, Kamysz W, Sibaev A, Storr M, Do Rego JC, Zjawiony JK, Fichna J. Novel orally available salvinorin A analog PR-38 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome. J Pharmacol Exp Ther 2014;350:69-78. [PMID: 24891526 DOI: 10.1124/jpet.114.214239] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
12 Pannemans J, Vanuytsel T, Tack J. New developments in the treatment of opioid-induced gastrointestinal symptoms. United European Gastroenterol J 2018;6:1126-35. [PMID: 30288274 DOI: 10.1177/2050640618796748] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Zielińska A, Sałaga M, Włodarczyk M, Fichna J. Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain. Int J Colorectal Dis 2019;34:217-27. [PMID: 30564910 DOI: 10.1007/s00384-018-3218-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
14 Kamysz E, Sałaga M, Sobocińska M, Giełdoń A, Fichna J. Anti-inflammatory effect of novel analogs of natural enkephalinase inhibitors in a mouse model of experimental colitis. Future Medicinal Chemistry 2016;8:2231-43. [DOI: 10.4155/fmc-2016-0156] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
15 Bui K, Birmingham B, Diva U, Berger B. An Open-Label, Randomized Bioavailability Study of Alternative Methods of Oral Administration of Naloxegol in Healthy Subjects. Clin Pharmacol Drug Dev 2017;6:420-7. [PMID: 28127938 DOI: 10.1002/cpdd.335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
16 Carli M, Donnini S, Pellegrini C, Coppi E, Bocci G. Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation. Pharmacological Research 2020;159:104938. [DOI: 10.1016/j.phrs.2020.104938] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Vallerand AH. Opioid-induced Constipation. The Journal for Nurse Practitioners 2017;13:170-174.e3. [DOI: 10.1016/j.nurpra.2016.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
18 Mazzotta E, Villalobos-Hernandez EC, Fiorda-Diaz J, Harzman A, Christofi FL. Postoperative Ileus and Postoperative Gastrointestinal Tract Dysfunction: Pathogenic Mechanisms and Novel Treatment Strategies Beyond Colorectal Enhanced Recovery After Surgery Protocols. Front Pharmacol 2020;11:583422. [PMID: 33390950 DOI: 10.3389/fphar.2020.583422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Cai L, He L. Placebo effects and the molecular biological components involved. Gen Psychiatr 2019;32:e100089. [PMID: 31552390 DOI: 10.1136/gpsych-2019-100089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Singh R, Zogg H, Ro S. Role of microRNAs in Disorders of Gut-Brain Interactions: Clinical Insights and Therapeutic Alternatives. J Pers Med 2021;11:1021. [PMID: 34683162 DOI: 10.3390/jpm11101021] [Reference Citation Analysis]
21 Szymaszkiewicz A, Włodarczyk J, Mazur M, Olczak J, Fichna J, Zielińska M. Cyclic derivatives of morphiceptin possess anti-transit effect in the gastrointestinal tract and alleviate abdominal pain in mice. Pharmacol Rep 2020;72:314-21. [PMID: 32125684 DOI: 10.1007/s43440-020-00084-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Zielińska M, Jarmuż A, Sałaga M, Lipkowski AW, Fichna J. Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms. Pharmacological Reports 2016;68:32-6. [DOI: 10.1016/j.pharep.2015.06.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
23 Dezfulian C, Orkin AM, Maron BA, Elmer J, Girotra S, Gladwin MT, Merchant RM, Panchal AR, Perman SM, Starks MA, van Diepen S, Lavonas EJ; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Council on Clinical Cardiology. Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association. Circulation 2021;143:e836-70. [PMID: 33682423 DOI: 10.1161/CIR.0000000000000958] [Reference Citation Analysis]
24 Fabisiak A, Sobocińska M, Kamysz E, Fichna J, Zielińska M. Antinociceptive potency of enkephalins and enkephalinase inhibitors in the mouse model of colorectal distension-proof-of-concept. Chem Biol Drug Des 2018;92:1387-92. [DOI: 10.1111/cbdd.13186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
25 Seo EJ, Efferth T, Panossian A. Curcumin downregulates expression of opioid-related nociceptin receptor gene (OPRL1) in isolated neuroglia cells. Phytomedicine 2018;50:285-99. [PMID: 30466988 DOI: 10.1016/j.phymed.2018.09.202] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
26 Salaga M, Storr M, Martemyanov KA, Fichna J. RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives. Bioessays 2016;38:344-54. [PMID: 26817719 DOI: 10.1002/bies.201500118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
27 Bu G, Cui L, Lv C, Lin D, Huang L, Li Z, Li J, Zeng X, Wang Y. Opioid Peptides and Their Receptors in Chickens: Structure, Functionality, and Tissue Distribution. Peptides 2020;128:170307. [PMID: 32217145 DOI: 10.1016/j.peptides.2020.170307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Deshpande D, Fuchs L, Klose CSN. Neuro-immune-metabolism: The tripod system of homeostasis. Immunol Lett 2021;240:77-97. [PMID: 34655659 DOI: 10.1016/j.imlet.2021.10.001] [Reference Citation Analysis]
29 Reiss D, Ceredig RA, Secher T, Boué J, Barreau F, Dietrich G, Gavériaux-Ruff C. Mu and delta opioid receptor knockout mice show increased colonic sensitivity. Eur J Pain 2017;21:623-34. [PMID: 27748566 DOI: 10.1002/ejp.965] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
30 Kienzl M, Storr M, Schicho R. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. Clin Transl Gastroenterol 2020;11:e00120. [PMID: 31899693 DOI: 10.14309/ctg.0000000000000120] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
31 Bao X, Wu J. Impact of food-derived bioactive peptides on gut function and health. Food Res Int 2021;147:110485. [PMID: 34399481 DOI: 10.1016/j.foodres.2021.110485] [Reference Citation Analysis]
32 Liu Z, Udenigwe CC. Role of food-derived opioid peptides in the central nervous and gastrointestinal systems. J Food Biochem 2019;43:e12629. [PMID: 31353498 DOI: 10.1111/jfbc.12629] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
33 Liu JJ, Brenner DM. Opioid-Related Constipation. Gastroenterology Clinics of North America 2022. [DOI: 10.1016/j.gtc.2021.10.007] [Reference Citation Analysis]
34 Liu Q, He H, Mai L, Yang S, Fan W, Huang F. Peripherally Acting Opioids in Orofacial Pain. Front Neurosci 2021;15:665445. [PMID: 34017236 DOI: 10.3389/fnins.2021.665445] [Reference Citation Analysis]
35 Wilenska B, Tymecka D, Włodarczyk M, Sobolewska-włodarczyk A, Wiśniewska-jarosińska M, Dyniewicz J, Somogyi Á, Fichna J, Misicka A. Enkephalin degradation in serum of patients with inflammatory bowel diseases. Pharmacological Reports 2019;71:42-7. [DOI: 10.1016/j.pharep.2018.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Sałaga M, Sobczak M, Fichna J. Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract. Drug Discovery Today 2013;18:708-15. [DOI: 10.1016/j.drudis.2013.03.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
37 Zatorski H, Salaga M, Zielińska M, Wasilewski A, Misicka A, Sacharczuk M, Fichna J. High activity of endogenous opioid system protects against gastric damage development in mouse models of gastric mucosal injury. Pharmacol Rep 2019;71:218-24. [PMID: 30785059 DOI: 10.1016/j.pharep.2018.10.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
38 Sałaga M, Zatorski H, Sobczak M, Chen C, Fichna J. Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review. Curr Treat Options Oncol 2014;15:405-20. [PMID: 24792017 DOI: 10.1007/s11864-014-0288-2] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
39 Beck TC, Hapstack MA, Beck KR, Dix TA. Therapeutic Potential of Kappa Opioid Agonists. Pharmaceuticals (Basel) 2019;12:E95. [PMID: 31226764 DOI: 10.3390/ph12020095] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
40 Maguire D, Gröer M. Neonatal abstinence syndrome and the gastrointestinal tract. Med Hypotheses 2016;97:11-5. [PMID: 27876117 DOI: 10.1016/j.mehy.2016.10.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Yan Y, Chen Y, Zhang X. The effect of opioids on gastrointestinal function in the ICU. Crit Care 2021;25:370. [PMID: 34689805 DOI: 10.1186/s13054-021-03793-1] [Reference Citation Analysis]
42 Fant RV, Henningfield JE, Cash BD, Dove LS, Covington PS. Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea. Clin Gastroenterol Hepatol 2017;15:1021-1029.e6. [PMID: 28167156 DOI: 10.1016/j.cgh.2017.01.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
43 Lesouhaitier O, Clamens T, Rosay T, Desriac F, Louis M, Rodrigues S, Gannesen A, Plakunov VK, Bouffartigues E, Tahrioui A, Bazire A, Dufour A, Cornelis P, Chevalier S, Feuilloley MGJ. Host Peptidic Hormones Affecting Bacterial Biofilm Formation and Virulence. J Innate Immun 2019;11:227-41. [PMID: 30396172 DOI: 10.1159/000493926] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
44 Dalziel J, Smolenski G, Mckenzie C, Haines S, Day L. Differential effects of sheep and cow skim milk before and after fermentation on gastrointestinal transit of solids in a rat model. Journal of Functional Foods 2018;47:116-26. [DOI: 10.1016/j.jff.2018.05.039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
45 Patrad E, Khalighfard S, Khori V, Alizadeh AM. The other side of the coin: Positive view on the role of opioids in cancer. Eur J Pharmacol 2022;923:174888. [PMID: 35367422 DOI: 10.1016/j.ejphar.2022.174888] [Reference Citation Analysis]
46 Kinuthia DG, Muriithi AW, Mwangi PW. Freeze dried extracts of Bidens biternata (Lour.) Merr. and Sheriff. show significant antidiarrheal activity in in-vivo models of diarrhea. Journal of Ethnopharmacology 2016;193:416-22. [DOI: 10.1016/j.jep.2016.09.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Zielińska M, Jarmuż A, Wasilewski A, Cami-Kobeci G, Husbands S, Fichna J. Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome. Pharmacol Rep 2017;69:350-7. [PMID: 28187396 DOI: 10.1016/j.pharep.2016.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
48 Mosińska P, Zielińska M, Fichna J. Expression and physiology of opioid receptors in the gastrointestinal tract: . Current Opinion in Endocrinology & Diabetes and Obesity 2016;23:3-10. [DOI: 10.1097/med.0000000000000219] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
49 Liu Q, Fan W, He H, Huang F. The role of peripheral opioid receptors in orofacial pain. Oral Dis 2021;27:1106-14. [PMID: 32437594 DOI: 10.1111/odi.13435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Svistunov AA, Butorova LI, Osadchuk MA, Kireeva NV, Tokmulina GM, Ardatskaya MD. The biliary pain syndrome in the context of Rome IV criteria: the rational approach to the choice of spasmolytic therapy in the clinical practice. Dok gastroenterol 2018;7:59. [DOI: 10.17116/dokgastro20187259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Zaborin A, Smith D, Garfield K, Quensen J, Shakhsheer B, Kade M, Tirrell M, Tiedje J, Gilbert JA, Zaborina O. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. MBio. 2014;5:e01361-e01314. [PMID: 25249279 DOI: 10.1128/mbio.01361-14] [Cited by in Crossref: 166] [Cited by in F6Publishing: 112] [Article Influence: 20.8] [Reference Citation Analysis]
52 Sobczak M, Fabisiak A, Murawska N, Wesołowska E, Wierzbicka P, Wlazłowski M, Wójcikowska M, Zatorski H, Zwolińska M, Fichna J. Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases. Pharmacol Rep 2014;66:766-75. [PMID: 25149979 DOI: 10.1016/j.pharep.2014.04.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
53 Chokhavatia S, John ES, Bridgeman MB, Dixit D. Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation. Drugs Aging 2016;33:557-74. [PMID: 27417446 DOI: 10.1007/s40266-016-0381-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
54 Tan KZ, Cunningham AM, Joshi A, Oei JL, Ward MC. Expression of kappa opioid receptors in developing rat brain - Implications for perinatal buprenorphine exposure. Reprod Toxicol 2018;78:81-9. [PMID: 29635048 DOI: 10.1016/j.reprotox.2018.04.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
55 Fragkos KC. Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea. Clin Exp Gastroenterol 2017;10:229-40. [PMID: 28989282 DOI: 10.2147/CEG.S123621] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
56 Szigethy E, Knisely M, Drossman D. Opioid misuse in gastroenterology and non-opioid management of abdominal pain. Nat Rev Gastroenterol Hepatol 2018;15:168-80. [PMID: 29139482 DOI: 10.1038/nrgastro.2017.141] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 9.8] [Reference Citation Analysis]
57 Srivastava S, Fergason-Cantrell EA, Nahas RI, Lever JR. Synthesis and opioid receptor binding of indium (III) and [111In]-labeled macrocyclic conjugates of diprenorphine: novel ligands designed for imaging studies of peripheral opioid receptors. Tetrahedron 2016;72:6127-35. [PMID: 28190898 DOI: 10.1016/j.tet.2016.08.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
58 Qi X, Tester RF. Starch containing formulations for diarrhoea therapy. Clin Nutr ESPEN 2018;28:36-40. [PMID: 30390891 DOI: 10.1016/j.clnesp.2018.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Schneider MP, Löffel LM, Furrer MA, Burkhard FC, Kleeb B, Curatolo M, Wuethrich PY. Can early oral prolonged-release oxycodone with or without naloxone reduce the duration of epidural analgesia after cystectomy? A 3-arm, randomized, double-blind, placebo-controlled trial. Pain 2018;159:560-7. [DOI: 10.1097/j.pain.0000000000001112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
60 Cirillo C, Capasso R. Constipation and Botanical Medicines: An Overview. Phytother Res 2015;29:1488-93. [PMID: 26171992 DOI: 10.1002/ptr.5410] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 7.9] [Reference Citation Analysis]
61 Lang-Illievich K, Bornemann-Cimenti H. Opioid-induced constipation: a narrative review of therapeutic options in clinical management. Korean J Pain 2019;32:69-78. [PMID: 31091505 DOI: 10.3344/kjp.2019.32.2.69] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Pourtalebi Jahromi L, Sasanipour Z, Azadi A. Promising horizon to alleviate Alzeheimer’s disease pathological hallmarks via inhibiting mTOR signaling pathway: A new application for a commonplace analgesic. Medical Hypotheses 2018;110:120-4. [DOI: 10.1016/j.mehy.2017.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
63 Sobczak M, Cami-Kobeci G, Sałaga M, Husbands SM, Fichna J. Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms. Eur J Pharmacol 2014;736:63-9. [PMID: 24815321 DOI: 10.1016/j.ejphar.2014.04.038] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
64 Weber HC. Opioid-induced constipation in chronic noncancer pain. Curr Opin Endocrinol Diabetes Obes 2016;23:11-7. [PMID: 26702846 DOI: 10.1097/MED.0000000000000220] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
65 Sałaga M, Mokrowiecka A, Jacenik D, Cygankiewicz AI, Małecka-panas E, Kordek R, Krajewska WM, Sobocinska MK, Kamysz E, Fichna J. Systemic Administration of Sialorphin Attenuates Experimental Colitis in Mice via Interaction With Mu and Kappa Opioid Receptors. Journal of Crohn's and Colitis 2017;11:988-98. [DOI: 10.1093/ecco-jcc/jjx043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
66 Rumman A, Gallinger ZR, Liu LWC. Opioid induced constipation in cancer patients: pathophysiology, diagnosis and treatment. Expert Review of Quality of Life in Cancer Care 2016;1:25-35. [DOI: 10.1080/23809000.2016.1131595] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
67 Leppert W. Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction. Drug Des Devel Ther 2015;9:2215-31. [PMID: 25931815 DOI: 10.2147/DDDT.S32684] [Cited by in Crossref: 43] [Cited by in F6Publishing: 20] [Article Influence: 6.1] [Reference Citation Analysis]
68 Richards JR. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department. The Journal of Emergency Medicine 2018;54:354-63. [DOI: 10.1016/j.jemermed.2017.12.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 8.8] [Reference Citation Analysis]
69 De Neve J, Barlow TMA, Tourwé D, Bihel F, Simonin F, Ballet S. Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors. RSC Med Chem 2021;12:828-70. [PMID: 34223156 DOI: 10.1039/d1md00041a] [Reference Citation Analysis]
70 Maruca A, Lupia A, Rocca R, Keszthelyi D, Corsetti M, Alcaro S. In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal. Int J Mol Sci 2020;21:E9127. [PMID: 33266221 DOI: 10.3390/ijms21239127] [Reference Citation Analysis]
71 Basso L, Garnier L, Bessac A, Boué J, Blanpied C, Cenac N, Laffont S, Dietrich G. T-lymphocyte-derived enkephalins reduce Th1/Th17 colitis and associated pain in mice. J Gastroenterol 2018;53:215-26. [PMID: 28424989 DOI: 10.1007/s00535-017-1341-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
72 Leng X, Zhang F, Yao S, Weng X, Lu K, Chen G, Huang M, Huang Y, Zeng X, Hopp M, Lu G. Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial. Adv Ther 2020;37:1188-202. [PMID: 32020565 DOI: 10.1007/s12325-020-01244-x] [Reference Citation Analysis]
73 Basso L, Boué J, Mahiddine K, Blanpied C, Robiou-du-Pont S, Vergnolle N, Deraison C, Dietrich G. Endogenous analgesia mediated by CD4(+) T lymphocytes is dependent on enkephalins in mice. J Neuroinflammation 2016;13:132. [PMID: 27245576 DOI: 10.1186/s12974-016-0591-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
74 Luo J, Feng J, Liu S, Walters ET, Hu H. Molecular and cellular mechanisms that initiate pain and itch. Cell Mol Life Sci 2015;72:3201-23. [PMID: 25894692 DOI: 10.1007/s00018-015-1904-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
75 Cissom C, J Paris J, Shariat-Madar Z. Dynorphins in Development and Disease: Implications for Cardiovascular Disease. Curr Mol Med 2020;20:259-74. [PMID: 31746302 DOI: 10.2174/1566524019666191028122559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Sobczak M, Zakrzewski PK, Cygankiewicz AI, Mokrowiecka A, Chen C, Sałaga M, Małecka-Panas E, Kordek R, Krajewska WM, Fichna J. Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases. Pharmacol Rep 2014;66:741-50. [PMID: 25149976 DOI: 10.1016/j.pharep.2014.03.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
77 Bashashati M, McCallum RW. Neurochemical mechanisms and pharmacologic strategies in managing nausea and vomiting related to cyclic vomiting syndrome and other gastrointestinal disorders. Eur J Pharmacol 2014;722:79-94. [PMID: 24161560 DOI: 10.1016/j.ejphar.2013.09.075] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
78 Fichna J, Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Cenac N, Sałaga M, Timmermans JP, Vergnolle N, Małecka-Panas E, Krajewska WM, Storr M. Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS. Neurogastroenterol Motil 2014;26:1539-50. [PMID: 25041572 DOI: 10.1111/nmo.12390] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
79 Ali Z, Shoukat U, Khan M, Roomi S, Ullah W. ' Loperamide overdose induces ventricular tachycardia with catastrophic outcomes'. J Community Hosp Intern Med Perspect 2020;10:229-32. [PMID: 32850070 DOI: 10.1080/20009666.2020.1766839] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
80 Pellissier LP, Gandía J, Laboute T, Becker JAJ, Le Merrer J. μ opioid receptor, social behaviour and autism spectrum disorder: reward matters. Br J Pharmacol 2018;175:2750-69. [PMID: 28369738 DOI: 10.1111/bph.13808] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 7.6] [Reference Citation Analysis]
81 Ghoshal A. Fentanyl, Morphine, and Opioid-Induced Constipation in Patients with Cancer-Related Pain. Indian J Palliat Care 2020;26:535-6. [PMID: 33623319 DOI: 10.4103/IJPC.IJPC_171_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Demin KA, Meshalkina DA, Kysil EV, Antonova KA, Volgin AD, Yakovlev OA, Alekseeva PA, Firuleva MM, Lakstygal AM, de Abreu MS, Barcellos LJ, Bao W, Friend AJ, Amstislavskaya TG, Rosemberg DB, Musienko PE, Song C, Kalueff AV. Zebrafish models relevant to studying central opioid and endocannabinoid systems. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;86:301-12. [DOI: 10.1016/j.pnpbp.2018.03.024] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
83 Zielińska M, Chen C, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Sałaga M, Małecka-panas E, Wlaź P, Krajewska WM, Fichna J. Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome. Journal of Pharmacy and Pharmacology 2015;67:244-54. [DOI: 10.1111/jphp.12335] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
84 Li YY, Ghanbari R, Pathmasiri W, McRitchie S, Poustchi H, Shayanrad A, Roshandel G, Etemadi A, Pollock JD, Malekzadeh R, Sumner SCJ. Untargeted Metabolomics: Biochemical Perturbations in Golestan Cohort Study Opium Users Inform Intervention Strategies. Front Nutr 2020;7:584585. [PMID: 33415121 DOI: 10.3389/fnut.2020.584585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
85 Golovynska I, Beregova TV, Falalyeyeva TM, Stepanova LI, Golovynskyi S, Qu J, Ohulchanskyy TY. Peripheral N-methyl-D-aspartate receptor localization and role in gastric acid secretion regulation: immunofluorescence and pharmacological studies. Sci Rep 2018;8:7445. [PMID: 29749407 DOI: 10.1038/s41598-018-25753-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
86 Wasilewski A, Storr M, Zielińska M, Fichna J. Role of G protein-coupled orphan receptors in intestinal inflammation: novel targets in inflammatory bowel diseases. Inflamm Bowel Dis 2015;21:666-73. [PMID: 25461621 DOI: 10.1097/MIB.0000000000000258] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
87 Sanchez MJ, Olivier S, Gediklioglu F, Almeida M, Gaeta M, Nigro M, de la Rosa R, Nguyen M, Lalehzari M, Regala F, Njei B, Deng Y, Ciarleglio M, Masoud A. Chronic opioid use is associated with obstructive and spastic disorders in the esophagus. Neurogastroenterol Motil 2021;:e14233. [PMID: 34532898 DOI: 10.1111/nmo.14233] [Reference Citation Analysis]
88 Imam MZ, Kuo A, Ghassabian S, Smith MT. Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression. Neuropharmacology 2018;131:238-55. [PMID: 29273520 DOI: 10.1016/j.neuropharm.2017.12.032] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
89 Szymaszkiewicz A, Storr M, Fichna J, Zielinska M. Enkephalinase inhibitors, potential therapeutics for the future treatment of diarrhea predominant functional gastrointestinal disorders. Neurogastroenterology & Motility 2019;31:e13526. [DOI: 10.1111/nmo.13526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
90 Bui K, Zhou D, Xu H, Floettmann E, Al-Huniti N. Clinical Pharmacokinetics and Pharmacodynamics of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist. Clin Pharmacokinet 2017;56:573-82. [PMID: 28035588 DOI: 10.1007/s40262-016-0479-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
91 Zhao T, Zhang Y, Lee J, Starkweather AR, Young EE, Cong X. The Associations of Single Nucleotide Polymorphisms with Risk and Symptoms of Irritable Bowel Syndrome. JPM 2022;12:142. [DOI: 10.3390/jpm12020142] [Reference Citation Analysis]
92 Salaga M, Mokrowiecka A, Zielinska M, Malecka-Panas E, Kordek R, Kamysz E, Fichna J. New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration. J Pharmacol Exp Ther 2017;363:92-103. [PMID: 28724693 DOI: 10.1124/jpet.117.242586] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
93 Malinky CA, Lindsley CW, Han C. DARK Classics in Chemical Neuroscience: Loperamide. ACS Chem Neurosci 2021;12:2964-73. [PMID: 34346690 DOI: 10.1021/acschemneuro.1c00382] [Reference Citation Analysis]
94 Sobczak M, Pilarczyk A, Jonakowski M, Jarmuż A, Sałaga M, Lipkowski AW, Fichna J. Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: New potential treatment of abdominal pain associated with inflammatory bowel diseases. Peptides 2014;60:102-6. [DOI: 10.1016/j.peptides.2014.08.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]